NASDAQ · SGRY
Healthcare · Medical - Care Facilities
$15.49
Down-$0.21 (-1.39%)
Updated Oct 21, 2026, 2:41 PM
SID Score
5.4/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance · SGRY
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 20, 2026
SGRY closed at $15.49 after 21 trading sessions, down 1.96% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 20, 2026 | $14.77 | $15.52 | $14.77 | $15.49 | 4.32M |
| Oct 19, 2026 | $14.57 | $14.89 | $14.49 | $14.71 | 1.31M |
| Oct 16, 2026 | $14.86 | $14.90 | $14.51 | $14.61 | 966.82K |
| Oct 15, 2026 | $15.05 | $15.34 | $14.615 | $14.77 | 2.37M |
| Oct 14, 2026 | $14.46 | $14.84 | $14.085 | $14.83 | 1.44M |
| Oct 13, 2026 | $14.35 | $14.77 | $14.255 | $14.55 | 1.14M |
| Oct 12, 2026 | $13.85 | $14.32 | $13.68 | $14.24 | 1.21M |
| Oct 9, 2026 | $13.69 | $14.06 | $13.605 | $13.89 | 929.01K |
| Oct 8, 2026 | $13.58 | $13.71 | $13.345 | $13.64 | 1.31M |
| Oct 7, 2026 | $13.36 | $13.965 | $13.34 | $13.71 | 1.69M |
| Oct 6, 2026 | $13.43 | $13.57 | $13.22 | $13.41 | 892.29K |
| Oct 5, 2026 | $13.26 | $13.50 | $13.16 | $13.33 | 1.57M |
| Oct 2, 2026 | $13.35 | $13.55 | $13.11 | $13.32 | 1.23M |
| Oct 1, 2026 | $13.81 | $14.28 | $13.14 | $13.23 | 1.87M |
| Sep 30, 2026 | $14.32 | $14.42 | $13.86 | $13.87 | 1.86M |
| Sep 29, 2026 | $14.65 | $14.775 | $14.25 | $14.41 | 1.42M |
| Sep 28, 2026 | $14.18 | $14.71 | $14.14 | $14.69 | 1.1M |
| Sep 25, 2026 | $14.22 | $14.67 | $14.19 | $14.40 | 1.76M |
| Sep 24, 2026 | $14.38 | $14.515 | $13.98 | $14.20 | 2.03M |
| Sep 23, 2026 | $15.72 | $15.84 | $14.43 | $14.56 | 3.72M |
| Sep 22, 2026 | $13.79 | $15.90 | $13.67 | $15.80 | 8.11M |
The latest Smart Investors Daily articles mentioning SGRY.
Company
Market Activity
Research & News
SGRY research
Company profile and research snapshot.
Surgery Partners Inc is a healthcare services company with an integrated outpatient delivery model focused on providing quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. It has one reportable segment: Surgical Facilities which includes the operation of ASCs, surgical hospitals, anesthesia services, and multi-specialty physician practices, which earns revenues from contracts with patients in which the performance obligations are to provide health care services.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Sep 30, 2026 | RBC Capital | Outperform | — |
| Sep 18, 2026 | TD Cowen | Buy | — |
| Sep 14, 2026 | JP Morgan | Neutral | — |
| Aug 11, 2026 | Cantor Fitzgerald | Overweight | — |
| Aug 11, 2026 | TD Cowen | Buy | — |
No generated briefing is available yet.
Yahoo · Oct 16, 2026
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.
Yahoo · Oct 10, 2026
Recent commentary around Surgery Partners (SGRY) has focused on softer unit sales over the past two years, a projected decline in sales over the next 12 months, and a relatively high forward P/E multiple. At a share price of US$13.89, Surgery Partners has seen short term momentum pick up, with a 1 day share price return of 1.83% and a 7 day share price return of 4.28%. However, the 90 day share price return is down 15.30% and the 1 year total shareholder return has fallen 29.64%, pointing to...
Yahoo · Oct 9, 2026
Surgery Partners has seen its share price fall sharply over recent years, which puts the spotlight squarely on whether the current valuation can be explained by the cash the business is expected to generate. With the stock recently closing at US$13.64, the key issue is how that market price lines up against the cash flow profile implied by a Discounted Cash Flow (DCF) view. Over the past 5 years, Surgery Partners has delivered a share price decline of 65.2%, which raises the question of what...
Yahoo · Oct 9, 2026
The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on. However, these companies often come with higher volatility and risk, as their smaller size makes them more vulnerable to economic downturns.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning SGRY.
